Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports enhanced binding affinity and selectivity toward specific enzyme targets. Commonly employed in medicinal chemistry for constructing bioactive molecules due to the stability and conformational rigidity provided by the cyclopropane ring. Also utilized in the preparation of fluorinated analogs to improve metabolic stability and membrane permeability in drug candidates.